Related by context. All words. (Click for frequent words.) 75 randomized trials 75 epidemiologic studies 75 meta analyzes 74 epidemiological studies 73 randomized controlled trials 72 meta analysis 71 randomized clinical trials 67 randomized controlled clinical trials 67 placebo controlled trials 67 placebo controlled studies 66 observational study 65 RCTs 65 subgroup analyzes 64 Observational studies 64 longitudinal studies 64 randomized controlled trial 63 randomized clinical 63 nonrandomized 62 vitamin D supplementation 62 calcium supplementation 61 randomized controlled trials RCTs 61 antioxidant supplements 61 Meta analyzes 61 prospective cohort 61 trials RCTs 60 generalizability 60 VADT 60 selenium supplementation 60 epidemiologic 60 studies 60 folate supplementation 59 Subgroup analyzes 59 dietary intake 59 randomized controlled 59 statin therapy 59 dietary intakes 59 Cochrane reviewers 59 lipid lowering therapy 58 statins 58 metaanalysis 58 ALLHAT 58 placebo controlled 58 correlational 58 placebo controlled clinical trials 58 beta carotene supplements 58 statin medications 58 magnesium intake 58 multicenter study 58 dietary antioxidants 58 beta carotene supplementation 58 thiazide diuretics 58 Epidemiologic studies 58 multicenter 57 prospective observational studies 57 methodological limitations 57 INTERHEART study 57 rosiglitazone 57 epidemiological 57 UKPDS 57 Prostate Cancer Prevention 57 folate intake 57 randomized 57 selenium supplements 57 postmenopausal women 57 probiotic supplementation 57 folic acid supplementation 57 multicenter trials 57 Cochrane Systematic Review 57 Epidemiological studies 57 PROactive study 57 dietary patterns 56 colorectal neoplasia 56 placebo controlled clinical 56 randomized placebo controlled 56 double blinded randomized 56 postmenopausal hormone therapy 56 substudy 56 antihypertensive therapy 56 Systematic reviews 56 pre menopausal 56 testosterone supplementation 56 ConclusionThis 56 RE LY 56 Winkelmayer 56 unmeasured confounders 56 biologically plausible 56 dose aspirin 56 statin 56 BARI 2D 56 DHA supplementation 56 generalisability 56 antioxidant supplementation 55 WHEL 55 PLCO 55 retrospective cohort study 55 nonrandomized studies 55 residual confounding 55 HOPE TOO 55 HIVNET 55 multicentre 55 Health Initiative WHI 55 pioglitazone 55 riociguat 55 cardioprotective effects 55 elevated CRP 55 randomized controlled clinical 55 HORIZONS AMI trial 55 ExTRACT TIMI 55 cardiovascular mortality 55 rosuvastatin 55 WHI 55 neuroimaging studies 55 fluvastatin 55 ischemic cardiovascular 55 IMPROVE HF 55 vitro studies 55 CARE HF 55 Framingham Offspring Study 54 ONTARGET 54 HYVET 54 fructose intake 54 nesiritide 54 prospective randomized 54 KRAS status 54 confounding variables 54 KIF6 carriers 54 Vitamin D supplementation 54 chromium supplementation 54 postmarketing surveillance 54 GnRH agonists 54 clinical trials 54 androgen suppression 54 methodologic 54 retrospective cohort 54 acrylamide intake 54 soy isoflavones 54 DASH diet 54 newer antipsychotics 54 serum cholesterol 54 NNRTI resistance 54 Cholesterol Levels SPARCL 54 neuropsychiatric symptoms 54 glycemic diet 54 tibolone 54 paricalcitol 54 macrovascular disease 54 MADIT II 54 stone formers 54 glitazones 54 strontium ranelate 54 causal inference 54 clinical trial 54 multivitamin supplements 54 vitamin B# supplements 54 NEJM 54 prospective observational 54 inverse association 54 magnesium supplementation 54 SPARCL 54 Clinical Antipsychotic Trials 53 intravenous bisphosphonates 53 cardiovascular morbidity 53 multicenter randomized 53 Prostate Lung Colorectal 53 Digital Mammographic Imaging 53 intensive statin therapy 53 APPROVe 53 Carotid Revascularization Endarterectomy vs. 53 observational cohort 53 randomized multicenter trial 53 vitamin D supplements 53 Polyp Prevention Trial 53 SGAs 53 NHANES III 53 ginkgo biloba extract 53 biological plausibility 53 prospectively defined 53 Randomized trials 53 folate deficiency 53 serum vitamin D 53 ATACAND 53 double blind placebo 53 AVERROES 53 HAART regimens 53 abnormal glucose tolerance 53 calcium intake 53 infantile colic 53 postmenopausal breast cancer 53 NHANES 53 SCD HeFT 53 postmenopausal 53 active comparator 53 β blockers 53 hypertensive patients 53 lignan intake 53 vitro experiments 53 inactivated influenza vaccines 53 Nissen meta analysis 53 CALGB 53 dietary fiber intake 53 pharmacologic treatments 53 B vitamin supplementation 53 liver transplant recipients 53 lipid lowering drugs 53 vitamin D inadequacy 53 selenium intake 53 commonly prescribed antidepressants 53 dietary modification 53 newer atypical antipsychotics 53 paclitaxel eluting stents 53 lipid abnormalities 53 LDL lowering 53 spontaneous preterm delivery 53 CAMMS# 53 antihypertensive medications 53 adiponectin levels 53 cilostazol 53 HeFT 53 nondiabetic patients 53 oral bisphosphonates 53 Dietary Modification Trial 53 SORT OUT III 53 colorectal adenomas 53 metreleptin 53 obese postmenopausal 53 phosphate binders 53 BOLDER II 53 rosiglitazone Avandia 53 subanalysis 53 antihypertensive drugs 53 dose statin therapy 53 dietary calcium intake 53 Screening Trial DMIST 52 DHEA supplementation 52 deferiprone 52 myocardial infarctions MIs 52 genetic polymorphisms 52 colorectal carcinogenesis 52 SYNTAX trial 52 Wactawski Wende 52 atypical antipsychotics 52 dose oral contraceptives 52 Edward Giovannucci 52 GISSI HF 52 Lipid Lowering Treatment 52 prospective longitudinal 52 NICE SUGAR 52 lowering LDL cholesterol 52 nulliparous women 52 heartwire 52 Netherlands Cohort Study 52 PLCO trial 52 macronutrient intake 52 eprotirome 52 cerebral microbleeds 52 prospective randomized controlled 52 HCV SPRINT 52 subclinical hypothyroidism 52 MERLIN TIMI 52 Previous observational studies 52 Stenting Trial CREST 52 SPIRIT III 52 AIM HIGH 52 randomized double 52 homocysteine levels 52 vitamin D deficiency 52 fat diets 52 DMIST 52 HF ACTION 52 Intervention Effectiveness 52 PROSTVAC TM 52 RE LY ® 52 rosuvastatin Crestor 52 chemoprevention trials 52 non selective NSAIDs 52 Ascherio 52 methodological flaws 52 biologic plausibility 52 longitudinal study 52 prucalopride 52 vitamin D 52 postmenopausal hormones 52 iPrEx study 52 Wisconsin Sleep Cohort 52 Dr. Yolton 52 lowering homocysteine 52 candesartan 52 unmeasured factors 52 canakinumab 52 adjuvant therapy 52 ACCORD Lipid 52 prospective randomized placebo 52 generalisable 52 NO# [002] 52 insulin detemir 52 colorectal adenoma 52 lipid levels 52 pharmacokinetic PK 52 flavonoid rich 52 inhaled corticosteroids 52 statin drugs 52 viral kinetic 52 dietary interventions 52 non aspirin NSAIDs 52 antiplatelet drugs 52 Intervention Trial GAIT 52 SPIRIT IV 52 INTERHEART 52 susceptibility loci 52 prospective observational cohort 52 dietary supplementation 52 dietary folate 52 isoflavone supplement 52 cardio protective 52 Protelos 52 celecoxib 52 study 52 aldosterone antagonist 52 ELCAP 52 mild gestational diabetes 52 calcium supplements 52 Stop Hypertension diet 52 salsalate 52 Lp PLA2 52 Pharmacokinetic 52 MADIT CRT trial 51 KIF6 gene variant 51 DCCT 51 pharmacokinetic pharmacodynamic 51 Demark Wahnefried 51 hormone therapy HT 51 Celecoxib 51 premenopausal women 51 multivariate analyzes 51 journal Ophthalmology 51 atorvastatin Lipitor 51 premenopausal 51 STEP BD 51 clinical pharmacology studies 51 hormone therapy estrogen 51 hydroxyvitamin D levels 51 longitudinal cohort study 51 cholinesterase inhibitors 51 anti arrhythmic drug 51 multicenter placebo controlled 51 premenopausal breast cancer 51 leukotriene receptor antagonists 51 glucose lowering 51 supplementation 51 CLA supplementation 51 endometrial hyperplasia 51 Swedish Mammography Cohort 51 antiepileptic drugs 51 perinatal outcomes 51 vegetable intake 51 subclinical hyperthyroidism 51 KRAS variant 51 vitamin E 51 gallstone disease 51 prostate carcinogenesis 51 TAXUS VI 51 fibrates 51 dronedarone 51 ASCEND HF 51 randomized multicenter 51 CARDIA study 51 statins cholesterol lowering 51 landmark ATHENA study 51 homocysteine lowering 51 post menopausal 51 CVD mortality 51 isoflavones 51 NCCTG N# 51 ECASS 51 pharmacological interventions 51 Intervention Effectiveness CATIE 51 nonpregnant women 51 CLBP 51 cholesterol lowering statins 51 statistically significant 51 GFT# 51 APTIVUS 51 pioglitazone Actos 51 periprocedural MI 51 meta regression 51 reboxetine 51 COPAXONE R 51 aldosterone antagonists 51 Longitudinal studies 51 stimulant medications 51 lacosamide 51 retrospective observational study 51 Communities ARIC study 51 surrogate endpoint 51 telomere lengths 51 post hoc 51 vitamin D intake 51 meta analytic 51 pharmacokinetic studies 51 RIO Lipids 51 zinc supplementation 51 metabolic parameters 51 hydroxychloroquine 51 WHIMS 51 transferrin saturation 51 newer antipsychotic medications 51 beta blocker therapy 51 HORIZONS AMI 51 HbA1c levels 51 Randomized controlled 51 menopausal hormone therapy 51 DSMB 51 Edge STudy 51 chromium picolinate 51 randomized Phase III 51 generation antipsychotics 51 carotid atherosclerosis 51 URTI 51 fasting triglyceride levels 51 potential confounders 51 Sackner Bernstein 51 NPH insulin 51 bile acid metabolism 51 vitamin supplementation 51 Hashibe 51 glycemia 50 Natural S equol 50 regression analyzes 50 EURIDIS 50 antidepressant efficacy 50 telmisartan 50 NSABP B 50 Conclusions 50 dietary questionnaires 50 bendamustine 50 ACUITY trial 50 lipid profiles 50 mammographic density 50 HPTN 50 preclinical efficacy 50 atherogenic dyslipidemia 50 confounders 50 RoACTEMRA 50 MDRD equation 50 BCIRG 50 insulin degludec 50 serum creatinine levels 50 singleton pregnancies 50 Val HeFT 50 adalimumab 50 creatine supplementation 50 Reynolds Risk Score 50 neurodevelopmental outcomes 50 nelfinavir 50 ENDEAVOR clinical 50 d4T 50 HMG CoA reductase inhibitors 50 aspirin therapy 50 elevated homocysteine 50 efficacy 50 glycemic load 50 ADAGIO study 50 prevalences 50 Concord grape juice 50 folic acid supplement 50 cardioprotective effect 50 SWOG 50 guggul 50 sulphonylureas 50 darunavir ritonavir 50 pharmacokinetics PK 50 NSAIDs 50 RE LY trial 50 multivitamin supplementation 50 phytoestrogens 50 montelukast 50 Rigorous scientific 50 CYPHER R Sirolimus eluting 50 REACH Registry 50 Interphone study 50 confounding factors 50 meta analysis pooling 50 IV bisphosphonates 50 Subgroup analysis 50 AVANDIA 50 serum uric acid 50 warfarin 50 dietary acrylamide 50 myopathy rhabdomyolysis 50 journal Lancet Neurology 50 atazanavir 50 metabolic syndrome 50 fasting glucose levels 50 cystatin C 50 QTc prolongation 50 insulin glargine 50 macrovascular 50 Nutrition Examination Survey NHANES 50 TRITON TIMI 50 CYP#D# inhibitor 50 multicentre study 50 epidemiologically 50 ARCOXIA 50 statistically nonsignificant 50 SSRIs 50 APPRAISE 50 Adenoma Prevention 50 PREVENT IV 50 thiazolidinediones 50 Multiple logistic regression 50 Boffetta 50 dose proportionality 50 adjuvant therapies 50 valsartan 50 aprotinin 50 clinically meaningful 50 cholesterol lowering medication 50 virologically 50 placebo controlled randomized 50 CC genotype 50 ezetimibe 50 risperidone Risperdal 50 prognostic factors 50 fluoxetine Prozac 50 Cardiovascular Risk 50 fatty acid supplementation 50 chlorthalidone 50 Rosuvastatin 50 landmark ATHENA 50 nutrient supplementation 50 elevated LDL cholesterol 50 flavonoid intake 50 oral rivaroxaban 50 Hepatotoxicity 50 noninferiority 50 Nutrition Examination Surveys NHANES 50 adjuvant chemotherapy 50 inhaled steroids 50 topical NSAIDs 50 HIV HCV coinfected 50 Leitzmann 50 Multiethnic Study 50 Ovarian Cancer Screening 50 lipid lowering medications 50 serum lipids 50 nonsignificant 50 sibutramine Meridia 50 genetic variants associated 50 borderline statistical significance 50 Clinical Nutrition 50 breastfed infants 50 antioxidant vitamin supplements 50 thromboprophylaxis 50 multicentre randomized 50 Complications Trial 50 APTIVUS r 50 orofacial clefts 50 adenoma recurrence 50 homocysteine concentrations 50 unmeasured confounding 50 chromium picolinate supplementation 50 Intervention Trial 50 CaPre ™ 50 QRISK 50 neurodevelopmental outcome 49 PRIMO CABG2 49 ACCORD ADVANCE 49 pramlintide 49 Remifemin R 49 dose regimens 49 black cohosh 49 Celecoxib APC trial 49 thrombotic events 49 salmeterol 49 atherothrombotic disease 49 vertebral fracture 49 oral antidiabetes drugs 49 slow metabolizers 49 PROactive Study 49 Diabetologia 49 CROI 49 GRNCM1 49 bisphosphonate drugs 49 thyrotropin levels 49 ToGA 49 CAVEATS 49 journal Epidemiology 49 double blinded placebo 49 coronary heart 49 Avandia Actos 49 tarenflurbil 49 sildenafil Viagra 49 ACOSOG Z# 49 multivariate Cox 49 inflammatory biomarkers 49 DAPT 49 myocardial infarctions 49 familial clustering 49 USPSTF 49 Shlipak 49 conditional logistic regression 49 blinded randomized controlled 49 isoflavone supplements 49 LDL cholesterol levels 49 methodologically rigorous 49 BRCA testing 49 RRMS patients 49 Health Initiative Observational 49 randomized crossover 49 dysglycemia 49 logistic regression analyzes 49 FOSRENOL R 49 ACTIVE W 49 OHR/AVR# 49 confounder 49 pure fructose 49 LibiGel Phase III 49 prescribe statins 49 triglyceride concentration 49 NCT# ClinicalTrials.gov 49 pegylated liposomal doxorubicin 49 Buijsse 49 pharmacokinetic characteristics 49 Aggressive Reduction 49 logistic regression models 49 letrozole 49 Medicine NEJM 49 Multicenter Automatic Defibrillator Implantation 49 Dr. Montori 49 comorbidity 49 anastrozole 49 estrogen progestin therapy 49 hawthorn extract 49 olmesartan 49 tolerability profile 49 psychotherapies 49 renal dysfunction 49 SpHb monitoring 49 MMRV vaccine 49 AVOREN 49 plasma lipid 49 sevelamer 49 bazedoxifene conjugated estrogens 49 triglyceride concentrations 49 poor metabolizers 49 coxibs 49 perimenopausal women 49 Multi Ethnic Study 49 virologic 49 nonfasting triglyceride levels 49 bezafibrate 49 dietary glycemic index 49 TAXUS ATLAS 49 journal Neurology 49 APPROVe trial 49 valacyclovir 49 dabigatran 49 estrogen progestin combination 49 fat vegan diet 49 univariate 49 d4T stavudine Zerit 49 routine episiotomy 49 dietary calcium 49 Atherosclerosis MESA 49 PM#.# exposure 49 nutrient intakes 49 serum GGT 49 triglyceride lowering 49 dietary carbohydrate 49 venous thromboembolic disease 49 LDL cholesterol concentrations 49 BRIM3 49 silibinin 49 multivariate analysis 49 TZDs 49 citalopram 49 dietary folate intake 49 APOE e4 49 Baseline characteristics 49 oral ibandronate 49 COX inhibitors 49 PRE SURGE 49 urate levels 49 red clover isoflavones 49 Randomised Study 49 calcium intakes 49 Slone Epidemiology Center 49 rofecoxib 49 multicenter randomized controlled 49 prospective randomized multicenter 49 elevated triglyceride levels 49 Motesanib 49 Chavarro 49 drug eluting stents 49 prospective multicenter 49 carotid artery stenting 49 antiepileptics 49 phase IIIb 49 pharmacogenetic testing 49 JoAnn Manson 49 skin sterol 49 multicentre prospective 49 multicenter clinical 49 chemopreventive agents 49 genistein 49 tHcy 49 Stacy Tessler Lindau 49 Observational Study 49 nonfasting 49 folic acid intake 49 placebo controlled Phase 49 iron supplementation 49 Boston DbTechNo Results 49 paroxetine Paxil 49 Cochrane Collaboration 49 pharmacological therapies 49 dietary fat 49 inhaled anticholinergics 49 genotypic resistance 49 Singh Manoux 49 mycophenolate mofetil 49 tocilizumab 49 statistical correlations 49 randomizing patients 49 Antioxidant supplements 49 #F FDG PET 49 postmarketing 49 tesofensine 49 serum lipid levels 49 EEG abnormalities 49 saturated fat intake 49 Clinical Endocrinology & 49 chromium supplements 49 Nutrition EPIC 49 comorbidities 49 oxysterols 49 SIBO 49 Dr. Pasinetti 49 morphometric vertebral fractures 49 causal relationship 49 tamoxifen 49 oral antidiabetic medication 49 antiplatelet therapies 49 adjuvanted vaccines 49 thimerosal exposure 49 mcg dose 49 GAMMAGARD 49 coinvestigators 49 Rasilez Tekturna 49 valvulopathy 48 Lp PLA 2 48 cranial irradiation 48 protease inhibitor PI 48 inhaled corticosteroid therapy 48 neoadjuvant 48 fosamprenavir 48 clinically meaningful differences 48 phytoestrogen 48 confirmatory clinical 48 EVEREST II 48 nonfatal MI 48 blind randomized placebo 48 Stop Hypertension DASH 48 cardiovascular 48 MADIT CRT 48 lasofoxifene 48 trans palmitoleic acid 48 Mylotarg 48 lumiracoxib 48 JAMA 48 non fasting triglycerides 48 tenofovir DF 48 serum markers 48 Bresalier 48 telcagepant 48 methodological weaknesses 48 FOSRENOL ® 48 gene variants 48 APOE genotype 48 lipid lowering therapies 48 coinfected patients 48 Meta Analysis 48 serotonin deficiency 48 anticholinergic drugs 48 ginkgo extract 48 atypical antipsychotic medications 48 oral antidiabetic agents 48 folate 48 Gag polymorphisms 48 recurrent miscarriage 48 Dangour 48 CATIE 48 XZK 48 oral bisphosphonate 48 oral FTY# 48 lipid lowering medication 48 prenatal exposures 48 Phase 1b trial 48 NSABP 48 clopidogrel 48 oophorectomy 48 Kivipelto 48 Dialysis Outcomes 48 valproate 48 plasma folate 48 reach statistical significance 48 genomewide association studies 48 venous thrombosis 48 afatinib 48 blind randomized controlled 48 hsCRP levels 48 Multivariate logistic regression 48 Francesca Bravi 48 GBA mutations 48 silent myocardial ischemia 48 Bibbins Domingo 48 ASTEROID 48 subclinical atherosclerosis 48 journal Obesity 48 SAMe 48 Torsades de Pointes 48 Study AREDS 48 Mechanistic studies 48 LUX Lung 48 hypercholesterolemia 48 abatacept 48 Kaplan Meier analysis 48 iPrEx 48 ApoE4 48 H. pylori eradication 48 non pharmacological interventions 48 L lysine 48 MGUS 48 postoperative mortality 48 ONGLYZA 48 donepezil 48 acamprosate 48 nomograms 48 contralateral breast cancer 48 Dr. Edward Giovannucci 48 journal Atherosclerosis 48 BETAS 48 anovulatory infertility 48 eicosapentaenoic acid EPA 48 eplerenone 48 MYH9 48 left ventricular dysfunction 48 symptomatic VTE 48 hippocampal volume 48 folic acid fortification 48 angiotensin receptor blockers 48 cardiovascular disease 48 rimonabant #mg 48 cardiometabolic risk 48 diuretic chlorthalidone 48 toxicological studies 48 hypertensives 48 daily subcutaneous injections 48 metformin sulfonylurea 48 glargine 48 serum calcium 48 Lancet 48 ticagrelor 48 Arteriosclerosis Thrombosis 48 dose Iluvien 48 avosentan 48 scientifically rigorous 48 retrospective observational 48 Serebruany 48 torcetrapib atorvastatin 48 SE alleles 48 wholegrain foods 48 alpha tocopherol 48 NEVO ™ 48 intracerebral haemorrhage 48 sitagliptin 48 hsCRP 48 NATRECOR ® 48 severe hypoglycemia 48 trivalent inactivated influenza 48 eculizumab therapy 48 tumor histology 48 atypicals 48 metformin 48 olaparib 48 vicriviroc 48 aleglitazar 48 antiplatelet therapy 48 Oreopoulos 48 CARDIA 48 adjuvant radiotherapy 48 dosage regimens 48 Ovarian PLCO Cancer 48 thromboembolic complications 48 nonvertebral fractures 48 number NCT# ClinicalTrials.gov 48 aripiprazole Abilify 48 ORMD 48 affective disorders 48 immunological responses 48 Univariate analysis 48 body fatness 48 Chodick 48 EGFR mutations 48 Primary endpoints 48 phase IIa 48 PREZISTA r 48 calorie diets 48 randomized blinded 48 INTERPHONE 48 atypical neuroleptics 48 haemorrhagic stroke 48 liver biopsies 48 secondary efficacy endpoints 48 safinamide 48 hyperintense lesions 48 fat diet 48 PRECiSE 48 loop diuretics 48 NSAID 48 inhaled budesonide 48 QT prolongation 48 COREG 48 teriparatide 48 warfarin therapy 48 Lancet Neurology journal 48 antitumor effect 48 antidiabetic medication 48 thromboembolic events 48 Burbacher 48 blinded randomized 48 antidepressants SSRIs 48 soy isoflavone 48 genetic loci 48 Pharmacological Research 48 ziprasidone 48 solifenacin 48 ascertainment bias 48 BUSM researchers 48 polyp recurrence 48 Djousse 48 CATIE AD 48 cardiac biomarkers 48 coronary calcification 48 genotypic 48 paroxysmal AF 48 ziprasidone Geodon 48 AZILECT 48 chest radiographs 48 carb diets 48 methodological differences 48 fibrate 48 bisphosphonate 48 aspirin clopidogrel 48 behavioral interventions 48 Logistic regression 48 carotid IMT 48 multicenter prospective 48 TMC# C# 48 pentoxifylline 48 rFVIIa 48 basal bolus regimen 48 Xelox 48 tamoxifen therapy 48 ACEIs 48 prostate cancer PCa 48 modifiable lifestyle 48 Randomised controlled trials 48 nonpharmacologic 48 antibiotic prophylaxis 48 Phase 2a trial 48 statistically significant correlations 48 ELBW infants 48 nutrient intake 48 pharmacokinetic interaction 48 normotensive 48 abstinent alcoholics 48 atypical antipsychotic drugs 48 AREDS 48 blind randomized 48 basal cell nevus syndrome 48 ICD therapy 48 CHARISMA trial 48 bosentan 48 PPIs 48 tolvaptan 48 RECORD1 48 Polypill 48 Trandolapril 48 adiposity 48 FOLPI 48 Antihypertensive 48 aspirin 48 preterm delivery 48 glatiramer acetate 48 clinicopathological 48 ibandronate 48 teriflunomide 48 AML MDS